Financials

  • Market Capitalization 95.31 M
  • Employee 5
  • Founded 2018
  • CEO N/A
  • Website www.ostherapies.com
  • Headquarter Delaware, United States
  • FIGI BBG00Y71N7G7
  • Industry Drug Manufacturers—General
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-1.43
Price to sales ratio